Welcome Message
 
Our Company
 
Awards & Recognition
 
Corporate Governance
 
Management Council
Board of Directors
Reports of Insider Transactions
Committee Charters
Corporate Governance Guidelines
Additional Policies and Guidelines
Codes of Conduct
Articles of Incorporation (PDF)
Bylaws (PDF)
 
Corporate Compliance
 
Our Websites
 
Business Links

 

  » BMS.com Home » About Us » Corporate Governance » Committee Charters - Compensation and Management
SEARCH INDEX
 





 

Committee Charters

Audit Committee
Committee on Directors and Corporate Governance
Compensation and Management Development Committee
Science and Technology Committee Charter
 

Compensation and Management Development Committee Charter [Download as PDF >>]

Purpose

The Compensation and Management Development Committee (“Committee”) is appointed by and acts on behalf of the Board of Directors (“Board”). It is responsible for reviewing, approving and reporting to the Board on major compensation plans, policies and programs of the Company. The Committee approves the compensation of executive officers and certain senior management, except the Chief Executive Officer, takes specific actions with respect to such compensation and has oversight responsibility over the Company’s management development programs, performance assessment of senior executives and succession planning.

Composition

The Committee shall consist of three or more independent directors of the Company designated by the Board and approved by a majority of the whole Board by resolution or resolutions. The members of the Committee shall meet the independence requirements of the New York Stock Exchange, Securities Exchange Commission and any standard of independence adopted by the Company in its Corporate Governance Guidelines. In addition, for purposes of meeting the requirements of Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), the Committee, or a sub-committee approving the performance goals to which certain of the executive compensation is tied, shall consist solely of at least two “outside” directors, as defined in Treasury Regulation 1.162-27(e)(3) of the Code. Each member of the Committee shall be a “Non-Employee Director” as defined in Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended. The foregoing notwithstanding, no action of the Committee shall be void or deemed to be without authority due to the failure of any member, at the time the action was taken, to meet any qualification standard set forth in this Charter.

The members of the Committee shall serve one-year terms. The members of the Committee shall serve until their resignation, retirement, or removal by the Board or until their successors shall be appointed. No member of the Committee shall be removed except by majority vote of the independent directors of the full Board then in office.

The Committee shall have the resources and authority appropriate to discharge its responsibilities, including the authority to consult outside advisors to assist in their duties to the Company. The Company shall provide for appropriate funding as determined by the Committee, for payment of compensation to any advisors employed by the Committee.

The Committee shall have the authority to delegate any of its responsibilities to one or more subcommittees, which shall be comprised of at least two members of the Committee.

Meetings

The Committee shall meet four times annually, or more frequently as circumstances dictate. The Committee may also request any officer or employee of the Company or the Company’s outside counsel or consultants to attend a meeting of the Committee or to meet with any members of, or consultants to, the Committee. A majority of the Committee members shall be present to constitute a quorum for the transaction of the Committee’s business.

Responsibilities and Duties

The Committee shall:

1.
 

annually evaluate the CEO’s performance against the approved performance goals and objectives. In reviewing the long-term incentive component of CEO compensation, the Committee will consider the Company’s performance and relative stockholder return, the value of similar incentive awards to CEOs at peer group companies, and the awards given to the CEO in past years, and other such matters deemed relevant.

2.
 

recommend for approval by at least three-fourths of the independent directors, the CEO’s compensation levels based on the evaluation of the CEO’s performance.

3.
 

annually review and approve the compensation of all other executive officers and certain other senior management.

4.
 

approve awards and make other determinations under plans and programs intended to provide “performance-based compensation” under Code Section 162(m), to the extent required in order to qualify such awards as “performance-based compensation” and otherwise to preserve the tax deductibility of compensation resulting from such awards.

5.
 

annually review senior management succession planning and organization structure, and periodically review Company policies and programs for the development of management personnel.

6.
 

if appropriate, hire experts in the field of executive compensation to assist the Committee with its evaluation of CEO or senior executive compensation. The Committee shall have the sole authority to retain and to terminate such experts, and to approve the experts’ fees and other retention terms. The Committee shall also have the authority to obtain advice and assistance from internal or external legal, accounting, human resource, or other advisors.

7.
 

make recommendations to the Board with respect to incentive-compensation plans and equity-based plans and interpret and administer such plans.

8.
 

appoint, monitor and terminate members of the Company’s Pension and Savings Plan Committees and the plan trustees, and monitor, adopt, amend and terminate the Company’s qualified and non-qualified savings and pension plans.

9.
 

form and delegate authority to subcommittees when appropriate.

10.
 

make regular reports to the Board.

11.
 

review and discuss with management the Company’s Compensation Discussion and Analysis and related disclosures required for inclusion in the Company’s annual report and proxy statement, recommend to the Board, based on review and discussions, whether the Compensation Discussion and Analysis should be included in the annual report and proxy statement, and produce the compensation committee report required for inclusion in the Company’s annual report and proxy statement.

12.
 

annually evaluate its own performance.

13.
 

review and reassess the adequacy of this Charter annually and recommend any proposed changes to the Board for approval.

14.
 

oversee the Company’s compensation philosophy and strategy.

15.
 

fulfill such other duties and responsibilities as may be assigned to the Committee, from time to time, by the Board and/or Chairman of the Board.





[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX